E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/11/2006 in the Prospect News Biotech Daily.

Minrad's Light Sabre line of procedure needles awarded CE Mark

By Lisa Kerner

Charlotte, N.C., Sept. 11 - Minrad International, Inc. received CE Mark approval for its Light Sabre line of disposable procedure needles, allowing the company to market the line throughout the European Union.

The company said the Light Sabre products, in conjunction with the SabreSource real-time image guidance system, provide physicians with accuracy during minimally invasive procedures through the alignment of light beams and specialized collimating tubes.

The Light Sabre line also meets the international quality requirements of ISO 13485:2003 and the Canadian Medical Devices Conformity Assessment System.

Minrad is an interventional pain-management company based in Orchard Park, N.Y.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.